Connealy Pamela Ann
SEC CIK 1796310 · EDGAR
BoughtSold
Most active insiders at OBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sherman Darren | See Remarks, Dir | $10.7K | $257.6K |
| 2 | Hochman David P | See Remarks, Dir | $149.2K | — |
| 3 | Fain Eric S | Dir | $82.6K | — |
| 4 | Aryeh Jason | Dir | $37.5K | — |
| 5 | RTW INVESTMENTS, LP | 10% | — | $132.16 |
| 6 | Cleary Chris | Dir | — | — |
| 7 | Mack John Prosper | Dir | — | — |
| 8 | Aiello Joshua | Principal Accounting Off | — | — |
| 9 | Connealy Pamela Ann | Dir | — | — |
| 10 | Taylor Andrew Lawrence | CFO | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-25 16:18 | 2026-06-23 | OBIO | Orchestra BioMed Holdings, Inc. | Connealy Pamela Ann | Dir | A - Grant | $0.00 | +17.3K | 66.0K | +36% | $0 |
| 2025-08-08 | 2025-08-07 | OBIO | Orchestra BioMed Holdings, Inc. | Connealy Pamela Ann | Dir | A - Grant | $0.00 | +15.0K | 48.7K | +44% | $0 | |
| D | 2025-06-26 | 2025-06-24 | OBIO | Orchestra BioMed Holdings, Inc. | Connealy Pamela Ann | Dir | A - Grant | $0.00 | +12.4K | 33.7K | +58% | $0 |
| MI | 2024-11-27 | 2024-11-26 | PYXS | Pyxis Oncology, Inc. | Connealy Pamela Ann | CFO, COO | P - Purchase | $1.96 | +88.8K | 1.20M | +8% | +$174.4K |
| D | 2024-06-21 | 2024-06-20 | OBIO | Orchestra BioMed Holdings, Inc. | Connealy Pamela Ann | Dir | A - Grant | $0.00 | +5,376 | 21.3K | +34% | $0 |
| 2024-03-28 | 2024-03-26 | PYXS | Pyxis Oncology, Inc. | Connealy Pamela Ann | CFO, COO | A - Grant | $0.00 | +328.7K | 1.11M | +42% | $0 | |
| 2023-11-30 | 2023-11-29 | PYXS | Pyxis Oncology, Inc. | Connealy Pamela Ann | CFO, COO | F - Tax | $1.40 | -36.9K | 781.6K | -5% | -$51.7K | |
| 2023-09-28 | 2023-09-28 | PYXS | Pyxis Oncology, Inc. | Connealy Pamela Ann | CFO, COO | P - Purchase | $1.87 | +8,000 | 818.5K | +1.0% | +$15.0K | |
| 2023-09-27 | 2023-09-27 | PYXS | Pyxis Oncology, Inc. | Connealy Pamela Ann | CFO, COO | P - Purchase | $1.85 | +6,426 | 810.5K | +0.8% | +$11.9K | |
| 2023-09-25 | 2023-09-25 | PYXS | Pyxis Oncology, Inc. | Connealy Pamela Ann | CFO, COO | P - Purchase | $1.67 | +12.0K | 804.1K | +2% | +$20.0K | |
| 2023-09-22 | 2023-09-22 | PYXS | Pyxis Oncology, Inc. | Connealy Pamela Ann | CFO, COO | P - Purchase | $1.74 | +5,000 | 792.1K | +0.6% | +$8,700 | |
| 2023-09-08 | 2023-09-07 | PYXS | Pyxis Oncology, Inc. | Connealy Pamela Ann | CFO, COO | A - Grant | $0.00 | +187.8K | 782.1K | +32% | $0 | |
| D | 2023-07-24 | 2023-07-20 | OBIO | Orchestra BioMed Holdings, Inc. | Connealy Pamela Ann | Dir | A - Grant | $0.00 | +11.7K | 15.9K | +275% | $0 |
| D | 2023-05-05 | 2023-04-12 | OBIO | Orchestra BioMed Holdings, Inc. | Yanchik Connealy Pamela | Dir | M - OptEx | — | +758 | 4,246 | +22% | — |
| D | 2023-03-28 | 2023-03-24 | PYXS | Pyxis Oncology, Inc. | Yanchik Connealy Pamela | CFO, COO | A - Grant | $0.00 | +209.8K | 594.3K | +55% | $0 |
| D | 2023-01-30 | 2023-01-26 | OBIO | Orchestra BioMed Holdings, Inc. | Yanchik Connealy Pamela | Dir | A - Grant | — | +3,488 | 3,488 | New | — |
| 2023-01-03 | 2023-01-03 | PYXS | Pyxis Oncology, Inc. | Yanchik Connealy Pamela | CFO | A - Grant | $0.00 | +43.5K | 384.5K | +13% | $0 | |
| 2022-04-15 | 2022-04-14 | PYXS | Pyxis Oncology, Inc. | Yanchik Connealy Pamela | CFO | A - Grant | $0.00 | +93.5K | 341.0K | +38% | $0 | |
| 2022-04-04 | 2022-03-31 | PYXS | Pyxis Oncology, Inc. | Yanchik Connealy Pamela | CFO | A - Grant | $0.00 | +247.5K | 247.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations